Finance

Gen Z relies on parental guidance for salary negotiations

A recent study indicates a growing trend among Gen Z individuals to involve their parents in crucial early-career financial discussions, particularly salary negotiations. This phenomenon highlights a generational shift in workplace confidence and preparedness, prompting experts to weigh the benefits and drawbacks of such parental involvement in shaping long-term career trajectories.

The Shifting Landscape of Early Career Negotiations

In the contemporary job market, a notable percentage of Gen Z workers, specifically almost three out of every ten, are turning to their parents for assistance during their inaugural salary negotiations. This finding stems from a comprehensive Zety survey of 1,001 Gen Z employees. The survey further illustrates that young adults frequently seek their parents' guidance for various career-related tasks, including resume refinement (44%) and initial employer outreach (21%).

For those navigating salary discussions, 18% received valuable advice from their parents, while a more direct 10% had a parent engage directly with the prospective employer. This trend underscores the significant financial implications of initial salary agreements, which can profoundly influence an individual's lifetime earnings, future raises, bonuses, and retirement contributions. Estimates suggest that neglecting to negotiate an initial salary could lead to a loss of $1 million to $1.5 million over a career, as per Carnegie Mellon research. A more conservative estimate by ZipRecruiter indicates that even a $5,000 disparity in starting pay can escalate to approximately $750,000 over 45 years due to compounding effects.

Despite these high stakes, a 2025 Resume Genius survey reveals that 55% of American workers do not negotiate their initial job offers. However, for those who do, the rewards are substantial, with 78% reporting improved offers. Notably, 65% of Gen Z workers who forewent negotiation expressed regret.

Jasmine Escalera, a career expert at Zety, attributes this hesitancy to a lack of formal education in compensation, benefits, and self-advocacy. This deficiency leaves young professionals feeling uncomfortable and inexperienced in negotiation, leading them to rely on more seasoned individuals. Additionally, early-career workers often undervalue their contributions, perceiving internships, academic achievements, or volunteer work as insufficient leverage, thus feeling a greater need for the job than the employer needs them.

Career development professionals emphasize a critical distinction between supportive guidance and direct intervention. Parental review of offer letters and coaching on talking points are considered beneficial mentoring. However, direct parental engagement with hiring managers during benefit negotiations is seen as potentially detrimental. The Zety survey indicates that 67% of Gen Z workers regularly receive career advice from their parents, with 32% citing parents as the primary influence on career decisions, 35% crediting their boss, and 34% acknowledging equal influence from both.

Escalera advises that the most effective parental support empowers young adults to lead their own conversations. This includes practicing negotiation scenarios, educating them on salary range research, and helping them articulate their value based on existing experiences. Parents can also serve as role models for self-advocacy and connect their children with mentors who can offer professional guidance.

Experts caution that individuals who fail to develop self-advocacy skills early in their careers may face challenges in requesting raises, addressing workplace conflicts, or navigating difficult managerial relationships without a parental safety net. This sentiment is echoed by many Gen Zers, with over half (55%) expressing embarrassment or displeasure if a parent contacted their boss without prior consent.

This evolving dynamic highlights the need for educational institutions and employers to better equip young professionals with the necessary skills for independent career management, fostering confidence and self-reliance in the competitive job market.

This shift in Gen Z's approach to career negotiation reveals a broader societal change where parental involvement extends further into young adulthood than in previous generations. While supportive guidance is undeniably valuable, there's a fine line between empowering young professionals and inadvertently hindering their development of essential self-advocacy skills. The long-term implications for independence, career progression, and personal growth warrant careful consideration from educators, employers, and parents alike. Fostering resilience and negotiation prowess in Gen Z will be crucial for their future success and economic well-being.

Coherus Oncology: Future Outlook and Clinical Trial Milestones

This report reiterates a positive outlook on Coherus Oncology, maintaining a 'Buy' recommendation despite recent market fluctuations. The company's innovative immunotherapy pipeline is a primary driver of this optimism, with several significant clinical milestones anticipated in the near future. The focus remains on the potential of its lead drug candidates to address unmet medical needs in oncology.

A critical period for Coherus Oncology is rapidly approaching, with mid-2026 set as the timeline for crucial data releases. Investors and stakeholders are eagerly awaiting the phase 2 results for casdozokitug, particularly its efficacy in treating hepatocellular carcinoma (HCC). Concurrently, the ongoing JUPITER-02 trial for toripalimab, targeting nasopharyngeal carcinoma, is expected to provide long-term survival data that could significantly impact the drug's market position and future prospects. These readouts are considered pivotal for the company's valuation and strategic direction.

While the clinical pipeline shows considerable promise, financial sustainability remains a key consideration. Coherus Oncology currently possesses approximately $115.2 million in cash and an additional $51.8 million in marketable securities. This capital is estimated to provide operational liquidity for two to three quarters based on the current cash burn rate. Should the burn rate decrease, this runway could potentially extend to four to five quarters. However, the need for further financing is a palpable concern, especially as the company approaches these critical clinical milestones that require substantial investment.

The competitive landscape for PD-1 inhibitors and the static revenue generation from toripalimab are factors that moderate overall enthusiasm. Despite these challenges, the forthcoming early-stage clinical data are the most significant elements influencing the company's valuation trajectory. Positive results from these trials could catalyze substantial growth and validate the strategic investments made in its immunotherapy platform. Conversely, any setbacks could intensify financial pressures and necessitate more immediate capital-raising efforts.

In summary, Coherus Oncology stands at a pivotal juncture, balancing promising clinical developments with financial management challenges. The success of upcoming data readouts for casdozokitug and toripalimab will be instrumental in shaping its future trajectory and determining its long-term viability in the competitive oncology market. Careful monitoring of both clinical progress and financial health is essential for assessing the company's investment potential.

See More

Understanding Actuarial Gains and Losses in Pension Accounting

This article delves into the concept of actuarial gains and losses within the realm of pension accounting. It explores how these adjustments arise from changes in key assumptions used to value defined benefit pension plans, such as discount rates and expected returns on assets. The discussion covers the different accounting treatments under U.S. GAAP and International Financial Reporting Standards (IFRS), highlighting their impact on financial reporting and volatility.

Navigating the Nuances of Pension Adjustments

Defining Actuarial Gains and Losses

An actuarial gain or loss signifies an alteration in the financial projections utilized to determine a corporation's commitments for defined benefit pension plans. These fluctuations stem from modifications in the actuarial presumptions, including the anticipated returns on plan assets or the discount rate employed to calculate the current value of future benefit payouts. Accounting regulations mandate that the funding status of pension funds be reported on a company's balance sheet, necessitating regular updates to pension obligations, fund performance, and the plan's overall financial well-being. Consequently, pension plans may experience either an actuarial gain or loss in their projected benefit obligation, contingent on various factors such as participation rates and market performance.

The Mechanics of Actuarial Adjustments

To fully grasp actuarial gains and losses, it's essential to understand the broader context of pension accounting. This explanation primarily focuses on U.S. Generally Accepted Accounting Principles (GAAP). While U.S. GAAP and International Financial Reporting Standards (IFRS) share similar principles for measuring pension benefit obligations, their approaches to reporting pension costs in the income statement, particularly regarding actuarial gains and losses, differ significantly. The funded status of a pension plan, representing the net asset or liability, is the disparity between the value of plan assets and the projected benefit obligation (PBO). While valuing plan assets involves judgment, measuring the PBO necessitates actuarial estimates, which are the source of actuarial gains and losses. These estimates encompass economic assumptions, such as the interest rate for discounting future cash outflows, expected asset returns, and anticipated salary increases, as well as demographic assumptions, like life expectancy and projected service periods.

Impact on Financial Stability

Fluctuations in actuarial assumptions, especially the discount rate, can lead to substantial increases or decreases in the PBO from one period to another. If these adjustments were directly recorded in the income statement, they could distort the comparability of financial results. Therefore, under U.S. GAAP, these adjustments are initially recorded within other comprehensive income in shareholders' equity and are subsequently amortized into the income statement over time. Conversely, IFRS requires these adjustments to be recognized in other comprehensive income but does not permit their subsequent amortization into the income statement.

Transparency Through Footnote Disclosures

Accounting standards require comprehensive disclosures regarding pension assets and liabilities. These include detailed information on period-to-period activity within accounts and the critical assumptions used to determine funded status. Such disclosures enable financial statement users to assess how a company’s pension plans influence its financial position and operating results, both in comparison to previous periods and to other companies.

Concluding Thoughts on Actuarial Accounting

Actuarial gains and losses are reflections of changes in the estimated obligations of defined benefit pension plans. These changes frequently stem from updated assumptions concerning discount rates, investment returns, or demographic factors such as life expectancy. The manner in which these adjustments are reported in financial statements varies between U.S. GAAP and IFRS. Furthermore, footnote disclosures are vital for investors to comprehend the influence of pension obligations and funding status on a company's financial health.

See More